Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database.
Patrick BlinMichael JoubertPatrick JourdainPhilippe ZaouiEstelle GuiardDunia SakrCaroline Dureau-PourninMarie-Agnès BernardRégis LassalleFlorence Thomas-DelecourtSébastien BineauNicholas MooreCécile Droz-PerroteauPublished in: Cardiovascular diabetology (2024)
While MI, stroke and PAD remain classic major risks of complications for CVRD-free type 2 diabetes, HF and CKD nowadays represent individually a higher risk and cost than each of these classic manifestations, and jointly represents a risk and a cost twice as high as these three classic manifestations all together. This should encourage the development of specific HF and CKD preventive strategies.
Keyphrases
- type diabetes
- chronic kidney disease
- end stage renal disease
- risk factors
- ejection fraction
- glycemic control
- cardiovascular disease
- atrial fibrillation
- prognostic factors
- insulin resistance
- peritoneal dialysis
- acute heart failure
- metabolic syndrome
- cross sectional
- patient reported outcomes
- risk assessment
- cerebral ischemia
- blood brain barrier
- adverse drug
- weight loss
- electronic health record